Dr. Rita Shaknovich is a physician scientist with more than fifteen years of leadership experience in senior executive roles in the laboratory industry and academia. She directed strategy at Cancer Genetics Inc and established and oversaw Clinical Labs and Medical Affairs strategy at Grail LLC. Dr. Shaknovich has directed accreditation and overseen several CLIA/CAP laboratories nationally and has been a key contributor to the development and commercial launch of first-in-class Galleri™ Multi-Cancer Early Detection liquid biopsy test. She developed an NGS assay product portfolio, developed biomarker-based assays across multiple platforms, and established relationships with key opinion
leaders and pharmaceutical clients. Dr. Shaknovich has been published in more than forty scientific articles in the field of cancer biology, genomics and epigenetics, and has designed and executed NIH-funded research projects with a focus on cancer biology and genomics. She has excellent analytical and problem-solving skills, is effective in highly matrixed environments, and is a team player with high moral standards and integrity.